Literature DB >> 12517810

Distinct HLA associations by stroke subtype in children with sickle cell anemia.

Carolyn Hoppe1, William Klitz, Janelle Noble, Lara Vigil, Elliott Vichinsky, Lori Styles.   

Abstract

Children with sickle cell anemia (SCA) carry a 200-fold increased risk for cerebral infarction. Stroke can be the result of small-vessel (SV) or large-vessel (LV) disease. However, it is unknown whether these subtypes result from the same pathophysiologic processes. Complete HLA genotyping was performed on 231 eligible children previously enrolled in the Cooperative Study of Sickle Cell Disease (CSSCD). Cerebral infarction on magnetic resonance imaging (MRI) was documented in 71 patients, and 160 patients had negative findings on MRI. Based on MRI/magnetic resonance angiography (MRA) findings, infarct size, and location, 36 patients were classified as having LV stroke and 35 as having SV stroke. When comparing the total MRI+ group with the MRI- group, HLA DPB1*0401 was associated with increased stroke risk (P =.01), whereas DPB1*1701 (P =.02) conferred protection from stroke. These DPB1 associations with stroke were attributed to the SV stroke group, in whom DPB1*0401 was associated with susceptibility (P =.003) and DPB1*1701 with protection from stroke (P =.06). In the LV stroke subgroup, HLA-A*0102 (P =.02) and -A*2612 (P =.007) conferred susceptibility, whereas -A*3301(P =.04) protected from stroke. These results suggest that specific HLA alleles influence stroke risk and appear to contribute differently to SV and LV stroke subtypes. The distinct HLA associations with SV and LV stroke suggest that different pathologic processes may be involved in the development of stroke in children with SCA. If these results are confirmed in a larger study, HLA type may serve as a useful marker for the early identification of SCA patients at high risk for stroke.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12517810     DOI: 10.1182/blood-2002-09-2791

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

1.  HLA class II haplotypes distinctly associated with vaso-occlusion in children with sickle cell disease.

Authors:  Najat Mahdi; Khadija Al-Ola; Abeer M Al-Subaie; Muhallab E Ali; Zaid Al-Irhayim; A Qader Al-Irhayim; Wassim Y Almawi
Journal:  Clin Vaccine Immunol       Date:  2008-02-13

2.  Evidence for ineffective erythropoiesis in severe sickle cell disease.

Authors:  Catherine J Wu; Lakshamanan Krishnamurti; Jeffery L Kutok; Melinda Biernacki; Shelby Rogers; Wandi Zhang; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2005-08-09       Impact factor: 22.113

3.  Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study.

Authors:  Paola Sebastiani; Nadia Solovieff; Stephen W Hartley; Jacqueline N Milton; Alberto Riva; Daniel A Dworkis; Efthymia Melista; Elizabeth S Klings; Melanie E Garrett; Marilyn J Telen; Allison Ashley-Koch; Clinton T Baldwin; Martin H Steinberg
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

4.  microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.

Authors:  Carolyn Sangokoya; Marilyn J Telen; Jen-Tsan Chi
Journal:  Blood       Date:  2010-08-13       Impact factor: 22.113

5.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

6.  Genetic endothelial systems biology of sickle stroke risk.

Authors:  Liming Chang Milbauer; Peng Wei; Judy Enenstein; Aixiang Jiang; Cheryl A Hillery; J Paul Scott; Stephen C Nelson; Vidya Bodempudi; James N Topper; Ruey-Bing Yang; Betsy Hirsch; Wei Pan; Robert P Hebbel
Journal:  Blood       Date:  2007-12-21       Impact factor: 22.113

7.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

8.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

9.  Treatment and prevention of stroke in children with sickle cell disease.

Authors:  Shyamal H Mehta; Robert J Adams
Journal:  Curr Treat Options Neurol       Date:  2006-11       Impact factor: 3.972

Review 10.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.